drugset / Trial / NCT01289626

Efficacy of Lanthanum Carbonate in Calciphylaxis

NCT01289626

Phase 1 Completed 12 enrolled University of Wisconsin, Madison Shire · collab
NaSingle-groupOpen-labelTreatment

Summary

The research question and primary aim is to determine if lanthanum carbonate is effective in treating calciphylaxis by measurement of complete or partial remission of skin lesions. Secondary endpoints will be measured to determine if lanthanum carbonate can lower calcium-phosphorus product levels, intact PTH and mortality. Albumin levels will be measured as a marker of nutritional status and inflammation.

Timeline

Start
2011-02
Primary completion
2013-03
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Lanthanum Carbonate Other / unclassified 3750 mg Oral

Indications